© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ONC PAN SOLID TUM ALYS DNA | Medium Descr | ONC PAN SOLID TUM ALYS DNA BMRK RSPSE ANTCA THER | Long Descr | Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Added | First appearance of addition in codebook. |
| 2024-01-01 | Added | Code Added. |
Get instant expert-level medical coding assistance.